“21-year-old Tverijonaite provided an in-competition sample during a World Tennis event in Mogyorod, Hungary, on 2 July 2026. On 29 July 2026, A World Anti-Doping Agency (WADA)-accredited laboratory confirmed the presence of canrenone.

“Canrenone is a diuretic and masking agent on the WADA Prohibited List and is banned at all times under the Tennis Anti-Doping Programme. Because of the nature of the substance, a provisional suspension is not mandatory under the rules.

“However, on 19 October 2026, Tverijonaite, who reached a career-high world singles ranking of 1067 in March 2023, elected to enter a voluntary provisional suspension.

“Voluntary provisional suspensions are open to any player under investigation by the ITIA in anti-doping cases. Time served under provisional suspension will be credited against any future sanction.

Tverijonaite has played in just three tournaments so far this year. Her last competitive match was in the qualifying round of the W50 tournament in Corroios-Seixal, Portugal, where she lost 6-2, 6-3 to French player Chloe Noel.

It is uncertain when she will return to tennis, as the investigation will determine the extent of any punishment. The ITIA also offers support to the players involved in anti-doping cases, and can help cover legal costs if necessary.